SCHEMBL25775483

SCHEMBL25775483

N#Cc1ccc(-c2ccccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c(-c2ccccc2-c2ccccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 15/20 0.50
▸ ABCB1 P08183 8/20 0.50
▸ ABCC1 P33527 3/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ CLK4 Q9HAZ1 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CYP19A1 P11511 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ ADORA2A P29274 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26553114 1.00 ABCG2 (0.50) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL25775534 0.95 ABCG2 (0.47) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL26553228 0.93 CYP1A2 (0.45) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL31196832 0.92 ABCG2 (0.47) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL25775359 0.91 CYP1A2 (0.46) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL26274604 0.89 ABCG2 (0.50) ABCG2ABCB1ABCC1MEN1KMT2A
SCHEMBL31643964 0.89 ABCG2 (0.50) ABCG2ABCB1ABCC1MEN1KMT2A
SCHEMBL25775360 0.89 CYP1A2 (0.47) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL26581893 0.89 CYP1A2 (0.47) ABCG2ABCB1ABCC1MEN1ALDH1A1
SCHEMBL26581950 0.88 ABCG2 (0.46) ABCG2ABCB1ABCC1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
EP-4206195-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME Lg Chem, Ltd. (KR) 2023-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME NR2E3, NR2E1, NR0B2 ABCG2 3682/4885ABCB1 4065/4885ABCC1 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback